Drug giants ponder life after a brief encounter

The collapse of the merger poses more questions for SmithKline than Glaxo as the two drug giants map out their future strategies, write Andrew Yates and Michael Harrison.

SmithKline claims it can go it alone successfully. But trying and failed to join forces with a competitor twice in the space of a month has severely dented its credibility. For Glaxo the deal was always an opportunistic one and yesterday it was at pains to stress that it did not need to pair up with another pharmaceutical partner.

Nevertheless for Sir Richard Sykes, Glaxo's chairman, it may prove a missed opportunity. He has set Glaxo the target of developing three significant medicines a year by the millennium against an industry average of one per year. That would have been a much easier goal with the economies of scale in research and development a SmithKline merger would have brought.

After an indifferent 1997, when it felt the full effects of the ending of patent protection on the blockbuster anti-ulcer drug Zantac, Glaxo's priority now will be to deliver on its promise to maintain earnings this year and then grow them significantly in 1999 on the back of double digit sales growth.

It has two new treatments in the pipeline for HIV, where its existing drugs, Epivir, Retrovirt and Combivir notched up a 16 per cent sales increase last year to pounds 1.8bn. Approval is also being sought in China to use Epivir as a treatment for Hepatitis B while Glaxo will file for regulatory approval later this year for a new flu treatment, Zanamivir. Other drugs in the pipeline include Seratide, a treatment for respiratory diseases, a sector of the market where Glaxo's existing drugs Flixotide and Serevent brought in sales of pounds 1.8bn last year.

Meanwhile SmithKline's failure to forge a deal has raised concerns about the future of the group and Jan Leschly, its chief executive. Potential partners could have been frightened off by the group's antics over the past month. "Who would want to work with Jan Leschly and Jean Pierre Garnier now. They want nothing less that to run any merged company," said one analyst. A hostile bid remains unlikely, with drugs rivals unwilling to give up costs savings by paying a premium for the group.

If SmithKline remains independent it will have to prove it can produce major new drugs over the next few years to replace Paxil, the group's answer to Prozac and Augmentin, its best selling anti-biotic. Only then can it restore investor confidence.

Underlying profits rose 17 per cent to pounds 1.65bn in 1997, but several of its most promising treatments failed to get through clinical trials and the group could struggle to produce this sort of growth rate in the future.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Recruitment Genius: Technical Report Writer

£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...

MBDA UK Ltd: Indirect Procurement Category Manager

Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...

Recruitment Genius: Web Developer - PHP

£16500 - £16640 per annum: Recruitment Genius: This fast growing Finance compa...

Day In a Page

Greece elections: In times like these, the EU has far more dangerous adversaries than Syriza

Greece elections

In times like these, the EU has far more dangerous adversaries than Syriza, says Patrick Cockburn
Holocaust Memorial Day: Nazi victims remembered as spectre of prejudice reappears

Holocaust Memorial Day

Nazi victims remembered as spectre of prejudice reappears over Europe
Fortitude and the Arctic attraction: Our fascination with the last great wilderness

Magnetic north

The Arctic has always exerted a pull, from Greek myth to new thriller Fortitude. Gerard Gilbert considers what's behind our fascination with the last great wilderness
Homeless Veterans appeal: Homeless in Wales can find inspiration from Daniel’s story

Homeless Veterans appeal

Homeless in Wales can find inspiration from Daniel’s story
Front National family feud? Marine Le Pen and her relatives clash over French far-right party's response to Paris terror attacks

Front National family feud?

Marine Le Pen and her relatives clash over French far-right party's response to Paris terror attacks
Pot of gold: tasting the world’s most expensive tea

Pot of gold

Tasting the world’s most expensive tea
10 best wildlife-watching experiences: From hen harriers to porpoises

From hen harriers to porpoises: 10 best wildlife-watching experiences

While many of Britain's birds have flown south for the winter, it's still a great time to get outside for a spot of twitching
Nick Easter: 'I don’t want just to hold tackle bags, I want to be out there'

'I don’t want just to hold tackle bags, I want to be out there'

Nick Easter targeting World Cup place after England recall
DSK, Dodo the Pimp, and the Carlton Hotel

The inside track on France's trial of the year

Dominique Strauss-Kahn, Dodo the Pimp, and the Carlton Hotel:
As provocative now as they ever were

Sarah Kane season

Why her plays are as provocative now as when they were written
Murder of Japanese hostage has grim echoes of a killing in Iraq 11 years ago

Murder of Japanese hostage has grim echoes of another killing

Japanese mood was against what was seen as irresponsible trips to a vicious war zone
Syria crisis: Celebrities call on David Cameron to take more refugees as one young mother tells of torture by Assad regime

Celebrities call on David Cameron to take more Syrian refugees

One young mother tells of torture by Assad regime
The enemy within: People who hear voices in their heads are being encouraged to talk back – with promising results

The enemy within

People who hear voices in their heads are being encouraged to talk back
'In Auschwitz you got used to anything'

'In Auschwitz you got used to anything'

Survivors of the Nazi concentration camp remember its horror, 70 years on
Autumn/winter menswear 2015: The uniforms that make up modern life come to the fore

Autumn/winter menswear 2015

The uniforms that make up modern life come to the fore